Abstract

BackgroundStudies suggest an increased prevalence of cognitive impairment (CI) among people with rheumatoid arthritis (RA). However, most prior studies have used convenience samples which are subject to selection biases or have failed to adjust for key confounding variables. We thus examined the association between CI and RA in a large national probability sample of older US adults.MethodsData were from interviews with 4462 participants in the 2016 wave of the nationally representative U.S. Health and Retirement Study with linked Medicare claims. RA diagnoses were identified via a minimum of two ICD-9CM or ICD-10 codes in Medicare billing records during the prior 2 years. The Langa-Weir Classification was used to classify cognitive status as normal, cognitively impaired non-dementia (CIND), or dementia based on a brief neuropsychological battery for self-respondents and informant reports for proxy respondents. We compared the odds of CI between older adults with and without RA using logistic regression, adjusted for age, education, gender, and race.ResultsMedicare records identified a 3.36% prevalence of RA (150/4462). While age, gender, education, and race independently predicted CI status, controlling for these covariates we found no difference in CI prevalence according to RA status (prevalent CI in 36.7% of older adults with RA vs. 34.0% without RA; adjusted OR = 1.08, 95% CI 0.74–1.59, p = .69).ConclusionThere was no association between RA and CI in this national sample of older U.S. adults.

Highlights

  • Studies suggest an increased prevalence of cognitive impairment (CI) among people with rheumatoid arthritis (RA)

  • Research suggests that some RA treatments may increase the risk of dementia [10]; several studies indicate both conventional Disease-Modifying Anti-Rheumatic Drugs and anti-TNF biologic DMARDS have either no effect or are protective against CI or dementia [4, 11,12,13,14]

  • Population characteristics (Table 1) One hundred and fifty out of 4462 eligible Health and Retirement Study (HRS) respondents were classified as having RA (3.36%), slightly above the population prevalence of RA in this age group reported elsewhere [29]

Read more

Summary

Introduction

Studies suggest an increased prevalence of cognitive impairment (CI) among people with rheumatoid arthritis (RA). Five population-based studies (not included in the review) using large samples from either registries or insurance databases found negative or null associations between RA and dementia or Alzheimer’s disease (AD) [11, 12, 22,23,24]. These studies used clinical diagnostic codes to identify RA and CI, and as a consequence, may have misclassified RA, missed subclinical cases of CI, or misclassified dementia/AD [25]. Volunteers recruited to “normal” or healthy control groups are likely to have higher cognitive functioning than the general population [26]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call